approval
saveBKEMV (ECULIZUMAB-AEEB) — FDA approval
community read0 votes
Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalMar 26, 2026 · 190d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalNov 24, 2025 · 312d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalApr 18, 2025 · 532d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalJan 30, 2025 · 610d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalOct 23, 2024 · 709d ago
- approvalBKEMV (ECULIZUMAB-AEEB) — FDA approvalMay 28, 2024 · 857d ago
same company · ±60 days · 6
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalSep 17, 2025
- approvalWEZLANA: WEZLANA (USTEKINUMAB-AUUB) — FDA approvalSep 25, 2025
- approvalWEZLANA: WEZLANA (USTEKINUMAB-AUUB) — FDA approvalSep 25, 2025
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalOct 16, 2025
- approvalblinatumomab: BLINCYTO (BLINATUMOMAB) — FDA approvalOct 21, 2025
- recallMckesson Medical-Surgical Inc. Corporate Office recall (Cls II)Jul 30, 2025
comments(0)
5-min edit window · permanent after that